Cargando…
A novel oral camptothecin analog, gimatecan, exhibits superior antitumor efficacy than irinotecan toward esophageal squamous cell carcinoma in vitro and in vivo
Esophageal squamous cell carcinoma (ESCC) is a frequently diagnosed and deadly malignancy with few standard therapeutic options. Camptothecins are considered one of the most promising antitumor drugs. A modified lipophilic analog, gimatecan, was synthesized as a novel oral camptothecin and showed im...
Autores principales: | Zou, Jianling, Li, Shuang, Chen, Zuhua, Lu, Zhihao, Gao, Jing, Zou, Jianyin, Lin, Xiaoting, Li, Yanyan, Zhang, Cheng, Shen, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5981453/ https://www.ncbi.nlm.nih.gov/pubmed/29855512 http://dx.doi.org/10.1038/s41419-018-0700-0 |
Ejemplares similares
-
Gimatecan exerts potent antitumor activity against gastric cancer in vitro and in vivo via AKT and MAPK signaling pathways
por: Chen, Zuhua, et al.
Publicado: (2017) -
A novel camptothecin derivative, ZBH-01, exhibits superior antitumor efficacy than irinotecan by regulating the cell cycle
por: Li, Yongqi, et al.
Publicado: (2023) -
In Vitro and In Vivo Anticancer Activity of Gimatecan against Hepatocellular Carcinoma
por: Zhao, Youna, et al.
Publicado: (2016) -
Targeting autophagy potentiates antitumor activity of Met-TKIs against Met-amplified gastric cancer
por: Lin, Xiaoting, et al.
Publicado: (2019) -
Establishment and genomic characterizations of patient-derived esophageal squamous cell carcinoma xenograft models using biopsies for treatment optimization
por: Zou, Jianling, et al.
Publicado: (2018)